Company performance
Current Price
as of Jan 21, 2025$1.18
P/E Ratio
N/A
Market Cap
$3.81M
- SEMR
Description
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Metrics
Overview
- HQSolana Beach, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerARTL
- Price$1.18+2.61%
Trading Information
- Market cap$3.81M
- Float99.17%
- Average Daily Volume (1m)27,069
- Average Daily Volume (3m)33,623
- EPS-$2.84
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$1.13M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$1.19M
- EV-$1.13M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.60
Documents
SEC Filings
Factset Street Account